Healthcare · LAXMIDEN
Medical Equipment
from 200 today
Laxmi Dental delivered an in-line revenue for the quarter with EBITDA and PAT beating expectations, driven by strong traction in the international market and revival in growth of the aligner business. Reiterate BUY with a target price of INR280.
Laxmi Dental delivered an in-line revenue for the quarter with EBITDA and PAT beating expectations, led by strong traction in the international market and a revival in the aligner business. We reiterate BUY with a target price of INR280, valuing the company at 27x 12M forward earnings.
Ratings and target prices as published by each firm. Each summary condenses that firm's stated view in its own note and is attributed to it; no report text is reproduced.
